跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,686 条关于
“Samsung EpiS Holdings”
全部
1,686
临床试验
420
药物
164
机构
171
资讯
931
10个月前
Samsung Establishes New Holding Company to Expand Beyond Biosimilars into Next-Generation Biotechnology
去年
Samsung Biologics to Spin Off Biosimilar Business to Focus on Core CDMO Services
8个月前
Samsung Bioepis Advances First Novel ADC Targeting Nectin-4 into Phase 1 Trials Following FDA Clearance
10个月前
Korean Biotech Platforms Drive Record $13.5 Billion in Technology Exports
10个月前
Samsung Biologics Completes Strategic Spinoff to Enhance Biosimilar and Novel Drug Development
10个月前
Samsung Bioepis Explores Organon Acquisition to Shift from Partner-Based to Direct Sales Model
2个月前
The Biosimilar Race: APAC's Factory to the World Confronts the Value Trap
去年
Samsung Bioepis to Become Wholly-Owned Subsidiary of Samsung Biologics in Strategic Restructuring
去年
Samsung Biologics Expands Into Preclinical Research with Launch of Samsung Organoids Drug Screening Platform
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
第 1 页,共 94 页
上一页
下一页